Log in
Enquire now
‌

US Patent 7144863 GLP-1 formulations with protracted time action

Patent 7144863 was granted and assigned to Eli Lilly and Company on December, 2006 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Eli Lilly
Eli Lilly
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
71448630
Date of Patent
December 5, 2006
0
Patent Application Number
104770340
Date Filed
May 21, 2002
0
Patent Citations Received
0
‌
US Patent 11840559 Glucagon-receptor selective polypeptides and methods of use thereof
0
Patent Primary Examiner
‌
Anish Gupta
0
Patent abstract

The present invention encompasses compositions wherein a GLP-1 compound is complexed with a basic polypeptide. The compositions provide a prolonged duration of action and can be administered by the pulmonary route.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7144863 GLP-1 formulations with protracted time action

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us